PAI-1 Promotes the Accumulation of Exudate Macrophages and Worsens Pulmonary Fibrosis Following Type II Alveolar Epithelial Cell Injury.

Authors:
Address: Division of Pulmonary and Critical Care Medicine. Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI. 48109; Research Service, Ann Arbor VA Health System, Department of Veterans Affairs Health System.
Journal:


Publication:

abstract

Fibrotic disorders of the lung are associated with perturbations in the plasminogen activation system. Specifically, plasminogen activator inhibitor-1 (PAI-1) expression is increased relative to the plasminogen activators. A direct role for this imbalance in modulating the severity of lung scarring Following Injury has been substantiated in the bleomycin model of Pulmonary Fibrosis. However, it remains unclear whether derangements in the plasminogen activation system contribute more generally to the pathogenesis of lung fibrosis beyond bleomycin injury. To answer this question, we employed an alternative model of lung scarring in which Type II Alveolar Epithelial Cells (AEC) are specifically injured by administering diphtheria toxin (DT) to mice genetically engineered to express the human DT receptor (DTR) off of the surfactant protein C promoter. This targeted AEC injury results in the diffuse Accumulation of interstitial collagen. In the present study, we found that this targeted type II cell insult also increases PAI-1 expression in the alveolar compartment. We identified AECs and lung Macrophages to be sources of PAI-1 production. To determine whether this elevated PAI-1 concentration was directly related to the severity of fibrosis, DTR+ mice were crossed into a PAI-1 deficient background (DTR+:PAI-1-/-). DT administration to DTR+:PAI-1-/- animals caused significantly less fibrosis than was measured in DTR+ mice with intact PAI-1 production. PAI-1 deficiency also abrogated the accumulation of CD11b+ Exudate macrophages that were found to express PAI-1 and type-1 collagen. These observations substantiate the critical function of PAI-1 in pulmonary fibrosis pathogenesis and provide new insight into a potential mechanism by which this pro-fibrotic molecule influences collagen accumulation. Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.



Related Articles
Plasminogen activator inhibitor-1 impairs alveolar epithelial repair by binding to vitronectin.
Am J Respir Cell Mol Biol. 2004
Plasminogen activator inhibitor-1 impairs alveolar epithelial repair by binding to vitronectin.
Lazar MH, Christensen PJ, Du M, Yu B, Subbotina NM, Hanson KE, Hansen JM, White ES, Simon RH, Sisson TH. Am J Respir Cell Mol Biol. 2004 Dec; 31(6):672-8. Epub 2004 Aug 12.
Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
Thorax. 2010
Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
Senoo T, Hattori N, Tanimoto T, Furonaka M, Ishikawa N, Fujitaka K, Haruta Y, Murai H, Yokoyama A, Kohno N. Thorax. 2010 Apr; 65(4):334-40.
The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice.
Blood. 2011
The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice.
Courey AJ, Horowitz JC, Kim KK, Koh TJ, Novak ML, Subbotina N, Warnock M, Xue B, Cunningham AK, Lin Y, et al. Blood. 2011 Aug 25; 118(8):2313-21. Epub 2011 Jul 6.
Review Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Crit Care Med. 2003
Review Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S. Crit Care Med. 2003 Apr; 31(4 Suppl):S213-20.
Review Serine proteases, inhibitors and receptors in renal fibrosis.
Thromb Haemost. 2009
Review Serine proteases, inhibitors and receptors in renal fibrosis.
Eddy AA. Thromb Haemost. 2009 Apr; 101(4):656-64.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.